TriangleNCT03215030 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- The study was terminated early due to discontinuation of development of modakafusp alfa for strategic reasons. The November 7 2024 data cut comprises the final full dataset for safety and efficacy.
- point Of Contact
- USMedInfo@tevapharm.com
- organization
- Teva Branded Pharmaceutical Products R&D LLC
- phone
- 1-888-483-8279
- title
- Study Director
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- The study was terminated early due to discontinuation of development of modakafusp alfa for strategic reasons. The November 7 2024 data cut comprises the final full dataset for safety and efficacy.
- point Of Contact
- USMedInfo@tevapharm.com
- organization
- Teva Branded Pharmaceutical Products R&D LLC
- phone
- 1-888-483-8279
- title
- Study Director
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice